|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Postoperative chemotherapy in gastric cancer,consisting of etoposide,doxorubicin and cisplatin,followed by radiotherapy with concomitant cisplatin:a feasibility study显示文摘 | Shulman K Haim N Wollner M | 2012 | Oncol Lett2012，3，5： | 1 |
| 2 | Phase I study of single-agent anti-programmed death-1(MDX-1106)in refractory solid tumors:safety,clinical activity,pharmacodynamics,and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 3 | Phase I study of single-agent anti-progTammed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 4 | Phase I study of single agent anti-programmed death-1 (MDX-1106) in refractory solid tumors : safety, clinical activity, pharrnacodynamies, and immunologic correlates显示文摘 | Brabmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 5 | Hormone replacement therapy in menopausal women: Past problems and future possibilities 显示文摘 | Schmidt JW Wollner D Cureio J | 2006 | Gyneeol Endoerinol2006，22，10： | 1 |
| 6 | Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors:safety, clinical activity, pharmacodynamics, and immunologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 7 | Application of surface acoustic waves for optimisation of biocompatibility of carboxymethylated dextran surfaces显示文摘 | Markovic G Mutschler T Wollner K | 2006 | Surface Coatings Technology2006，201，3： | 1 |
| 8 | The potential of 5- hydryoxytryptophan for hot flash reduction : a hypothesis 显示文摘 | Curcio JJ Kim LS Wollner D | 2005 | Altern Med Rev2005，10，3： | 1 |
| 9 | Phase Ⅰ study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 10 | A pilot study to examine a combination botanical for the treatment of menopausal symptoms显示文摘 | Smolinski D Wollner D Orlowski J | 2005 | J Altern Complement Med2005，11，3： | 1 |
| 11 | Soluble endothelial proteinC receptor and coagulation parameters as prognostic factors innon-small cell lung carcinoma显示文摘 | Sarig G Meir A Wollner M | 2013 | J Thromb Haemost2013，11，4： | 1 |
| 12 | Desmoplastic small round cell tumor: prolonged progression-free survival with aggressive muhimodality therapy显示文摘 | Kushner BH LaQuaglia MP Wollner N | 1996 | J Clin Oncol1996，14，5： | 1 |
| 13 | A pilot study to examine a combination botanical for the treatment of menopausal symptoms 显示文摘 | Smolinski D Wollner D Orlowski J | 2005 | J Altern Complement Med2005，11，3： | 1 |
| 14 | Nutrition support in the intensive care unit: an evolving science 显示文摘 | Blackburn GL Wollner S Bistrian BR | 2010 | Arch Surg2010，145，6： | 1 |
| 15 | Effect of Hepatic Arterial Yttrium - 90 Glass Microspheres显示文摘 | Blanchard R J Wollner I Knutsen C | 1995 | Cancer1995，18，： | 1 |
| 16 | Phase Ⅰ study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors:safety,clinical activity,pharmacodynamics,and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 17 | Desmoplastic small round-cell tumor:prolonged progression free survival with aggressive multimodality therapy显示文摘 | Kushner B H LaQ uaglia MP Wollner N | 1996 | J Clin Oncol1996，14，5： | 1 |
| 18 | Phase I study ofsingle-agent anti-programmed death-1 (MDX-1106) inrefractory solid tumors: safety, clinical activity,pharmacodynamics, and immunologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J ClinOncol2010，28，19： | 1 |
| 19 | Phase I study of sin- gle-agent anti-programmed death-1 (MDX-1106) in refractory sol-id tumors: Safety, clinical activity, pharmacodynamics, and im- munologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 20 | Phase I study of single-agent anti-programmed death-I (MDX-ll06) in refractory solid tumors: safety, clinical activity, pharmaco-dynamics, and immunologic correlates显示文摘 | BRAHMERJ R DRAKE C G WOLLNER I | 2010 | J Clin Oncol2010，28，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员